Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2003
11/26/2003EP1363664A2 Synthetic vaccine agents
11/26/2003EP1363663A2 Nucleic acid mucosal immunization
11/26/2003EP1363662A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo ; analysis of vaccinating composition in vitro
11/26/2003EP1363661A2 Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use
11/26/2003EP1363660A2 Superior molecular vaccine based on self-replicating rna, suicidal dna or naked dna vector, that links antigen with polypeptide that promotes antigen presentation
11/26/2003EP1363653A2 Methods and compositions for enhancing angiogenesis
11/26/2003EP1363647A1 A method to enhance the immune system and used for the prevention and treatment of infectious diseases
11/26/2003EP1224471B1 Dpi-6, a therapeutic biomarker in neurological disorders
11/26/2003EP0871492B1 Mesothelium antigen and methods and kits for targeting it
11/26/2003EP0859627B1 Mimicking peptides in cancer therapy
11/26/2003EP0705278B1 Apoptose inhibitor
11/26/2003EP0635054B1 Mammalian melanocyte stimulating hormone receptors and uses
11/26/2003EP0590058B1 HUMANIZED Heregulin ANTIBODy
11/26/2003CN1458936A HIV peptides from Tat, Rev and Nef conserved regions and their application as E.G. vaccine components
11/26/2003CN1458282A Preparing method for producing high level immunity induced by nucleic molecule and using method
11/26/2003CN1458280A Two artificial synthetic PRRS virus multiple opitope tandem pucleotide sequences and their use
11/26/2003CN1458167A Truncated express pig gyrate virus Ôàí type capsid protein antigen and its use
11/26/2003CN1457885A Rhinitis and nasosinusitis resisting specific IgY and its combined preparation
11/26/2003CN1457884A Double virus inactivating/removing method for venous injection human immune globulin
11/26/2003CN1128876C Transferrin receptor genes of moraxella
11/26/2003CN1128637C Nerve growth factor as vaccine adjuvant
11/26/2003CN1128618C Use of histamine for elevating blood histamine
11/25/2003US6653461 Cytotoxic T lymphocyte epitopes of the major outer membrane protein of Chlamydia trachomatis
11/25/2003US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same
11/25/2003US6653446 Nucleotide sequences which code enzymatic polypeptide for use in treatment of gout, kidney, blood and preferential genetic disorders
11/25/2003US6653443 Viral infectivity factor protein (Vif) antagonist that binds to the multimerization domain within a Vif protein in a cell and inhibits Vif protein; treating acquired immunodeficiency syndrome (AIDS)
11/25/2003US6653382 Ethylene-unsaturated carboxylic acid copolymer; ionomers; resilience, melt processability
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6653287 Use of leukemia inhibitory factor and endothelin antagonists
11/25/2003US6653134 Obtaining a bone marrow sample from a human, isolating stromal cells, and administering to the central nervous system of the patient; treating a genetic disease, a tumor, trauma and stroke
11/25/2003US6653130 Method for the development of an HIV vaccine
11/25/2003US6653128 Especially for rickettsial pathogen selected from the group consisting of Rickettsia spp., Ehrlichia spp., Anaplasma spp., and Cowdria
11/25/2003US6653127 Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide
11/25/2003US6653125 Synthetic hepatitis C genes
11/25/2003US6653103 For inhibiting export of nucleic acids from nucleus to cytoplasm of a cell
11/25/2003US6653069 Method for quality control of an attenuated vericella live vaccine
11/25/2003US6652859 Diagnosis and therapy
11/25/2003US6652858 Administering an OX-2 protein or a nucleic acid encoding it to preventing graft rejection, fetal loss, autoimmune disease, and allergies; immunosuppressants; gene therapy
11/25/2003US6652857 Methods for producing avian verotoxin antitoxin
11/25/2003US6652856 Method for the treatment of fibrosis
11/25/2003US6652855 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/25/2003US6652854 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening
11/25/2003US6652853 Useful for treating patients with colorectal cancer and gastric carcinomas; particularly useful for treating patients who have tumors that are resistant to one or more chemotherapeutic agents and/or have metastasized.
11/25/2003US6652851 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
11/25/2003US6652848 Dendritic cell hybrids
11/25/2003US6652847 Attenuated strains of leishmania and uses thereof
11/25/2003CA2194166C Multi-stage cascase boosting vaccine
11/25/2003CA2086888C Whooping cough vaccine
11/21/2003CA2428112A1 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
11/20/2003WO2003096017A1 Methods and compositions for inducing an immune response
11/20/2003WO2003095971A2 Posh nucleic acids, polypeptides and related methods
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003WO2003095663A2 Modified t lymphocytes and uses therefor
11/20/2003WO2003095656A1 Recombinant fowlpox virus
11/20/2003WO2003095642A2 Polyepitopes and mini-genes for cancer treatment
11/20/2003WO2003095641A1 Intracellular protein delivery compositions and methods of use
11/20/2003WO2003095621A2 Apoptotic ebv-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferactive disorder
11/20/2003WO2003095492A1 Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies
11/20/2003WO2003095487A2 Immunogenic cd1 complexes
11/20/2003WO2003095486A1 Use of a peptide derived from the beta-subunit of hcg in order to generate an anti-tumour ctl-type response
11/20/2003WO2003095481A1 Streptococcal superantigens spe-l and spe-m
11/20/2003WO2003095480A2 Brachyspira hyodysenteriae vaccine
11/20/2003WO2003095477A2 Miniprotein ligands and other polypeptides and methods for making and using same
11/20/2003WO2003095476A2 PEPTIDES FOR REGULATION OF UROKINASE (uPA) AND TISSUE TYPE (tPA) PLASMINOGEN ACTIVATOR AND METHOD OF OPTIMIZING THERAPEUTIC EFFICACY
11/20/2003WO2003094974A1 Complexes for the delivery of biologically-active material to cells
11/20/2003WO2003094964A1 Allergy vaccine composition, production method thereof and use of same in allergy treatment
11/20/2003WO2003094963A2 Methylated immunostimulatory oligonucleotides and methods of using the same
11/20/2003WO2003094962A2 Ebv vaccine using gp350 antigen
11/20/2003WO2003094961A1 Improved polysaccharide and glycoconjugate vaccines_____________
11/20/2003WO2003094960A2 Mucosal combination vaccines for bacterial meningitis
11/20/2003WO2003094959A1 Improved polysaccharide and glycoconjugate vaccines
11/20/2003WO2003094957A2 Methods of therapy for inducing tolerance
11/20/2003WO2003094921A2 Utilization of inhibitors of egfr-mediated signal transduction for the treatment of benign prostatic hyperplasia (bph)/prostatic hypertrophy
11/20/2003WO2003094859A2 Epha2 monoclonal antibodies and methods of use thereof
11/20/2003WO2003094850A2 Lipid a and other carbohydrate ligand analogs
11/20/2003WO2003094849A2 Ferritin fusion proteins for use in vaccines and other applications
11/20/2003WO2003094846A2 Intrathecal and intratumoral superantigens to treat malignant disease
11/20/2003WO2003094840A2 Induction of antigen specific immunologic tolerance
11/20/2003WO2003094836A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/20/2003WO2003094834A2 Mucosal vaccines with chitosan adjuvant and meningococcal antigens
11/20/2003WO2003094829A2 Pathogen vaccines and methods for using the same
11/20/2003WO2003094828A2 Cancer vaccines and methods of using the same
11/20/2003WO2003073995A3 Dna vaccine against proliferating endothelial cells and methods of use thereof.
11/20/2003WO2003072016A3 Pharmaceutical compositions in particulate form
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003068145A3 Herbal immune system stimulant
11/20/2003WO2003065971A9 Non-myeloablative tolerogenic treatment with tyrphostins
11/20/2003WO2003055915A3 Human netrin receptor and uses thereof
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003053461A3 Lactic acid bacteria for preventing infection with intimin expressing pathogens
11/20/2003WO2003050504A3 Methods and compositions to treat cardiovascular disease usin g 1419, 58765 and 2201
11/20/2003WO2003049752A3 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
11/20/2003WO2003046124A3 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
11/20/2003WO2003044172A3 Composition comprising and method of using angiopoietin-like protein 3 angptl3
11/20/2003WO2003042357A3 Enzymes
11/20/2003WO2003040308A3 Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo
11/20/2003WO2003040183A3 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
11/20/2003WO2003023041A3 Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use
11/20/2003WO2003020909A3 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
11/20/2003WO2003020756A3 Hybrid and tandem expression of neisserial proteins
1 ... 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 ... 1823